Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study by Scott D. Newsome, Lawrence Goldstick, Derrick S. Robertson, James D. Bowen, Robert T. Naismith, Ben Townsend, Catarina Figueiredo, Heidemarie Kletzl, Mylene Giraudon, Oscar Bortolami, Dusanka Zecevic, Caroline Giacobino, Susanne Clinch, Yun‐An Shen, Gurpreet Deol-Bhullar, Robert A. Bermel

Get full text